Mon Dec 01, 2003
Who is Maya Leabman?
Maya Leabman is a postdoctoral fellow who is both developing a pharmacogenetics consortium between the School and industry and conducting her own research in pharmacogenetics. She works with Kathy Giacomini, chair, Department of Biopharmaceutical Sciences.
Mon Sep 01, 2003
Who is Nobuhisa Shimba?
Nobuhisa Shimba is a visiting scientist working in Charles Craik’s Department of Pharmaceutical Chemistry lab at Mission Bay. Each of the three School of Pharmacy departments welcome visiting scholars from industry or other educational institutions for varying lengths of time. Nobu comes to us from the Ajinomoto Company, Kawasaki, Japan. He grew up in Shizuoka, located between Tokyo and Osaka, the home of Mt. Fuji.
Wed Jul 09, 2003
The UCSF School of Pharmacy will establish its first distinguished professorship following a gift from one of its most illustrious alums. Harry Wm. Hind—inventor of both the Lidoderm® patch and the wetting solution that helped bring contact lenses into widespread use—and his wife, Diana V. Hind, have given US$2.65 million to establish the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Science.
Tue Jul 01, 2003
Reactions to Mission Bay moves. Ideas for generating revenue to offset the California budget deficit. How we gather input and advice to shape our planning. Awards and retirements (Kuntz, McCart, Ruggiero, Sutherland). Relocation of the Office of Student and Curricular Affairs. New School of Medicine Dean David Kessler, MD. Harry W. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences.
Fri Apr 04, 2003
Irwin (Tack) D. Kuntz, PhD, professor, Department of Pharmaceutical Chemistry, UCSF School of Pharmacy has been named the 2003 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).
Thu Mar 06, 2003
A plan seeded in 1996 by the World Health Organization for an international agreement, [Framework Convention on Tobacco Control] [link defunct]," is undergoing final discussions by member states before submission to the World Health Assembly in May. The plan outlines a global regulatory system aimed at controlling the tobacco pandemic, which, if no action is taken, is expected to claim an estimated 10 million lives by the late 2020s.
Thu Mar 06, 2003
UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control policies and the fight against nicotine addiction and tobacco use prevention. Those opposed to the ban argued that the issue is one of academic freedom in choosing funding sources.
Mon Feb 03, 2003
California budget deficit leads to UC cuts and student fee increases. Scientists move in to Mission Bay. 2003 PharmD applications up 32% over 2002. ACPE Accreditation approved. Exit survey and post-graduate survey results. Honors and awards (The Annals of Pharmacotherapy, Kuntz, Pohorille, Nguyen, Whitely).
Thu Jan 02, 2003
Tom James, PhD, chair of the department of pharmaceutical chemistry, UCSF School of Pharmacy, is looking for new drug models that act directly on RNA rather than protein, where most drug work is now being done. Why? See UCSF Magazine, "X is for Marking the Spot," August 2002.